- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT03374969
Differential DNA Methylation as a Function of a Parenting Intervention
15. desember 2017 oppdatert av: Mary Dozier, University of Delaware
Differential DNA Methylation as a Function of a Parenting Intervention: A Randomized Clinical Trial
The aim of this study is to experimentally assess whether an early parenting intervention for maltreating parents results in differential epigenetic marking of children's genome, particularly of DNA associated with immune system functioning, obesity, and mental health.
Studieoversikt
Status
Fullført
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
This study assesses whether a 10-session intervention for maltreating parents effects the epigenome of young children who have experienced early maltreatment.
Families are randomly assigned to the experimental condition (Attachment and Biobehavioral Catch-Up) or a treatment control (Developmental Education for Families).
Biological samples and behavioral observations of parenting will be collected pre- and post- intervention.
Biological samples will be used to conduct whole genome analyses of differential DNA methylation that occur as a result of the intervention.
Behavioral observations of parent-child interactions will be used to assess the efficacy of the intervention in altering parenting behaviors.
Studietype
Intervensjonell
Registrering (Faktiske)
44
Fase
- Ikke aktuelt
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
6 måneder til 2 år (Barn)
Tar imot friske frivillige
Ja
Kjønn som er kvalifisert for studier
Alle
Beskrivelse
Inclusion Criteria:
- Parents will be considered potentially eligible if they have a child between the ages of 6 and 20 months and have a history of substantiated or unsubstantiated report of maltreatment or domestic violence. After obtaining informed consent, observational assessments of sensitivity will be conducted, allowing screening of parents with low levels of sensitivity (who are expected to benefit more from the intervention than others). Only those parents who have scores in the insensitive range will be included in the full study.
Exclusion Criteria:
- Children with known serious medical issues (e.g., cerebral palsy) will be excluded from the sample. Also, high-risk parents will be screened for sensitivity to ensure that they will benefit from the intervention. Only those who are screened as relatively insensitive (1-2 on a 5 point coding scale) will be included in the full study.
- If the primary caregiver loses custody of the child before completion of the project, the participant will be withdrawn from the study.
- If the primary caregiver is incarcerated before completion of the study, the subject will be withdrawn from the study.
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Dobbelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Attachment and Biobehavioral Catch-Up
|
Attachment and Biobehavioral Catch-up (ABC) is a 10-session, weekly intervention delivered in the family's home.
ABC addresses three primary issues.
First, young children who have experienced early adversity are especially in need of nurturance and parents who behave in synchronous ways and delight in them.
Next, when parents behave in frightening ways, it is difficult for children to look to them for reassurance when distressed.
This can be particularly difficult for children who have experienced early adversity.
Therefore, this intervention helps parents learn how to: 1) behave in nurturing ways when children are distressed; 2) behave in synchronous, delighted ways when children are not distressed; and 3) avoid behaving in frightening or intrusive ways.
Interventionists are provided with a manualized protocol, but tailor specific session content to each family's needs.
Sessions are videotaped, both for playback to families, and for supervision.
|
|
Aktiv komparator: Developmental Education for Families
|
Developmental Education for Families (DEF) is a 10-session, weekly intervention delivered in the family's home.
DEF focuses on enhancing gross and fine motor skills, cognition and language development.
The age-based protocols (i.e., 6-24 months,) provide information about the developmental themes of focus for each week and suggest activities to enhance the target skills for that week.
However, the protocols do not provide a direct script with which to conduct the sessions.
Interventionists tailor the developmental program session to the needs of the child and family by considering the child's current gross, fine, cognitive and language skills and creatively preparing several activities that will address the session topics.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Whole Genome DNA Methylation
Tidsramme: from date of enrollment to 1 month after completing the intervention
|
from date of enrollment to 1 month after completing the intervention
|
Sekundære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Parental Sensitivity
Tidsramme: On date of enrollment, each intervention session, and 1 month after completing the intervention
|
On date of enrollment, each intervention session, and 1 month after completing the intervention
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Sponsor
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart (Faktiske)
9. desember 2013
Primær fullføring (Faktiske)
16. desember 2014
Studiet fullført (Faktiske)
10. februar 2017
Datoer for studieregistrering
Først innsendt
12. desember 2017
Først innsendt som oppfylte QC-kriteriene
12. desember 2017
Først lagt ut (Faktiske)
15. desember 2017
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
19. desember 2017
Siste oppdatering sendt inn som oppfylte QC-kriteriene
15. desember 2017
Sist bekreftet
1. desember 2017
Mer informasjon
Begreper knyttet til denne studien
Andre studie-ID-numre
- 511457
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Nei
Studerer et amerikansk FDA-regulert enhetsprodukt
Nei
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .